Hot Features
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company’s product c... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company’s product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.2 | 2.77777777778 | 7.2 | 7.525 | 6.38 | 237915 | 6.90704442 | CS |
| 4 | -0.73 | -8.9790897909 | 8.13 | 8.3999 | 6.3701 | 96949 | 7.19388139 | CS |
| 12 | -3.07 | -29.3218720153 | 10.47 | 14.98 | 6.3701 | 83020 | 8.98044544 | CS |
| 26 | 1 | 15.625 | 6.4 | 14.98 | 5.66 | 62561 | 8.71782477 | CS |
| 52 | 5.47 | 283.419689119 | 1.93 | 16.34 | 1.85 | 103585 | 7.25298192 | CS |
| 156 | 6.03 | 440.145985401 | 1.37 | 16.34 | 0.8981 | 76215 | 4.62875994 | CS |
| 260 | 3.3 | 80.487804878 | 4.1 | 16.34 | 0.8311 | 51726 | 4.52048732 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.